Advertisement

Topics

Eisai, Charles River Laboratories extend drug discovery partnership

13:46 EDT 5 Jun 2017 | CentreWatch

Eisai, a global research and development-based pharmaceutical company, and Charles River Laboratories International, an early-stage CRO, announced an agreement to extend their two-year collaboration in integrated drug discovery for another year. The continued collaboration strengthens the ongoing partnership between the two companies, focusing on the discovery of novel treatments for tropical and neurological diseases at Eisai’s […]

The post Eisai, Charles River Laboratories extend drug discovery partnership appeared first on CenterWatch News Online.

Original Article: Eisai, Charles River Laboratories extend drug discovery partnership

NEXT ARTICLE

More From BioPortfolio on "Eisai, Charles River Laboratories extend drug discovery partnership"

Quick Search
Advertisement
 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...